Research Tracker›Biomarker Atlas›PACVS›Vaccine mRNA (hybrid 3'UTR motifs)

Vaccine mRNA (hybrid 3'UTR motifs) in PACVS

Vaccine mRNA (hybrid 3'UTR motifs), also described as mtRNR1 / AES sequences, belongs to the molecular group of PACVS (PACVS, PCVS) markers, but reports against Viral RNA point in different directions. The cited literature links this alteration to distinguishes vaccine from viral RNA. The finding is drawn from Camperi et al. 2025; it describes group-level differences, not a threshold that classifies an individual.

↕ InconsistentMolecular

Summary

Direction in PACVS↕ Inconsistent — reported as both higher and lower across studies, with no consistent direction
CategoryMolecular
Also described asmtRNR1 / AES sequences
Compared againstViral RNA
Associated symptomsDistinguishes vaccine from viral RNA
Test typeClinical or physiological test
SourceCamperi et al. 2025 — doi:10.3390/molecules30071629
Condition atlasPACVS Biomarker Atlas

Related Molecular markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is Vaccine mRNA (hybrid 3'UTR motifs) high or low in PACVS?

Mixed. Some studies report higher and others lower Vaccine mRNA (hybrid 3'UTR motifs) in PACVS compared with Viral RNA, so no single direction is established. Source: Camperi et al. 2025.

What symptoms is Vaccine mRNA (hybrid 3'UTR motifs) associated with in PACVS?

The cited literature associates this marker with Distinguishes vaccine from viral RNA. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Vaccine mRNA (hybrid 3'UTR motifs)?

It is measured as a clinical or physiological test. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal Vaccine mRNA (hybrid 3'UTR motifs) result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. Vaccine mRNA (hybrid 3'UTR motifs) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). Vaccine mRNA (hybrid 3'UTR motifs) in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/vaccine-mrna-hybrid-3utr-motifs.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.